Eli Lilly said its psoriasis treatment ixekizumab showed positive results in phase 3 studies, preparing the way for its submission to regulatory authorities.
from WSJ.com: US Business http://ift.tt/1BFCBXx
via IFTTT
from WSJ.com: US Business http://ift.tt/1BFCBXx
via IFTTT
No comments:
Post a Comment